注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
台睿生物科技股份有限公司是一家主要从事新药开发的台湾公司。该公司主要研发癌症治疗药物及败血症辅助治疗药物。该公司的主要产品包括CVM-1118、Rexis、Zelnite、TRX-NOC、TRX-920、TRX-711、TRX-105等。CVM-1118及Rexis处于临床试验阶段,Zelnite药品通过经销商销往国内各级医疗院所。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Sheng-Chu Kuo | - | - | Director |
Jang-Yang Chang | - | - | Member of Scientific Advisory Committee |
Andrew Lin | - | - | Chairman of The Board |
Sarah Lee | - | - | Director |
Lucas Lin | - | - | Independent Director |
Yi-Wen Chu | - | - | Senior VP & Director |
Mary J.C. Hendrix | - | - | Member of Scientific Advisory Committee |
Tian-Shung Wu | - | - | Director |
Hsien-Shou Kuo | - | - | Independent Director |
Chia Hsiang Chang | - | - | Independent Director |
Harry M. Olson | - | - | Member of Scientific Advisory Committee |
Frank Shen | - | - | Director |
Chien Du-Shieng | - | - | Co-Founder, President, CEO & Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核